Intravenous Infusions Plc (GHSE:IIL)

Market Cap	21.95M +7.6%
Revenue (ttm)	9.30M -62.7%
Net Income	-4.63M
EPS	-0.02
Shares Out	274.41M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6
Open	n/a
Previous Close	0.0800
Day's Range	n/a
52-Week Range	0.0400 - 0.0800
Beta	0.12
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 10, 2026

About Intravenous Infusions

Intravenous Infusions Plc, a pharmaceutical company, engages in the manufacturing and marketing of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region. It provides pethidine, such as chloroquine phosphate and quinine dihydrochloride injections. The company was incorporated in 1969 and is based in Koforidua, Ghana.

• Industry: Pharmaceutical Preparations
• Founded: 1969
• Country: Ghana
• Stock Exchange: Ghana Stock Exchange
• Ticker Symbol: IIL

Financial Performance

In 2025, Intravenous Infusions's revenue was 9.30 million, a decrease of -62.69% compared to the previous year's 24.94 million. Losses were -4.63 million, 620.5% more than in 2024.